Literature DB >> 27645313

Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.

Nina M Patrick1, Chanel A Griggs2, Ali L Icenogle2, Maryam M Gilpatrick2, Vineela Kadiyala3, Rosa Jaime-Frias2, Catharine L Smith4.   

Abstract

Small molecule inhibitors of lysine deacetylases (KDACs) are approved for clinical use in treatment of several diseases. Nuclear receptors, such as the glucocorticoid receptor (GR) use lysine acetyltransferases (KATs or HATs) and KDACs to regulate transcription through acetylation and deacetylation of protein targets such as histones. Previously we have shown that KDAC1 activity facilitates GR-activated transcription at about half of all cellular target genes. In the current study we examine the role of Class I KDACs in glucocorticoid-mediated repression of gene expression. Inhibition of KDACs through two structurally distinct Class I-selective inhibitors prevented dexamethasone (Dex)-mediated transcriptional repression in a gene-selective fashion. In addition, KDAC activity is also necessary to maintain repression. Steroid receptor coactivator 2 (SRC2), which is known to play a vital role in GR-mediated repression of pro-inflammatory genes, was found to be dispensable for repression of glucocorticoid target genes sensitive to KDAC inhibition. At the promoters of these genes, KDAC inhibition did not result in altered nucleosome occupancy or histone H3 acetylation. Surprisingly, KDAC inhibition rapidly induced a significant decrease in H3K4Me2 at promoter nucleosomes with no corresponding change in H3K4Me3, suggesting the activation of the lysine demethylase, LSD1/KDM1A. Depletion of LSD1 expression via siRNA restored Dex-mediated repression in the presence of KDAC inhibitors, suggesting that LSD1 activation at these gene promoters is incompatible with transcriptional repression. Treatment with KDAC inhibitors does not alter cellular levels of LSD1 or its association with Dex-repressed gene promoters. Therefore, we conclude that Class I KDACs facilitate Dex-induced transcriptional repression by suppressing LSD1 complex activity at selected target gene promoters. Rather than facilitating repression of transcription, LSD1 opposes it in these gene contexts.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glucocorticoid; Lysine deacetylase; Lysine demethylase; Repression; Transcription

Mesh:

Substances:

Year:  2016        PMID: 27645313      PMCID: PMC5444329          DOI: 10.1016/j.jsbmb.2016.09.014

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  60 in total

1.  Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Authors:  Ivan Garcia-Bassets; Young-Soo Kwon; Francesca Telese; Gratien G Prefontaine; Kasey R Hutt; Christine S Cheng; Bong-Gun Ju; Kenneth A Ohgi; Jianxun Wang; Laure Escoubet-Lozach; David W Rose; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

Review 2.  The HAT/HDAC interplay: multilevel control of STAT signaling.

Authors:  Laura Icardi; Karolien De Bosscher; Jan Tavernier
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-16       Impact factor: 7.638

3.  Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes.

Authors:  Marcus Bantscheff; Carsten Hopf; Mikhail M Savitski; Antje Dittmann; Paola Grandi; Anne-Marie Michon; Judith Schlegl; Yann Abraham; Isabelle Becher; Giovanna Bergamini; Markus Boesche; Manja Delling; Birgit Dümpelfeld; Dirk Eberhard; Carola Huthmacher; Toby Mathieson; Daniel Poeckel; Valérie Reader; Katja Strunk; Gavain Sweetman; Ulrich Kruse; Gitte Neubauer; Nigel G Ramsden; Gerard Drewes
Journal:  Nat Biotechnol       Date:  2011-01-23       Impact factor: 54.908

4.  Role of transcriptional coregulator GRIP1 in the anti-inflammatory actions of glucocorticoids.

Authors:  Yurii Chinenov; Rebecca Gupte; Jana Dobrovolna; Jamie R Flammer; Bill Liu; Francesco E Michelassi; Inez Rogatsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 5.  Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions.

Authors:  Simon G Royce; Tom C Karagiannis
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-02

6.  A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes.

Authors:  Sujit S Nair; Da-Qiang Li; Rakesh Kumar
Journal:  Mol Cell       Date:  2013-01-24       Impact factor: 17.970

7.  Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.

Authors:  Niveen M Mulholland; Edlyn Soeth; Catharine L Smith
Journal:  Oncogene       Date:  2003-07-31       Impact factor: 9.867

Review 8.  Dynamic regulation of transcriptional states by chromatin and transcription factors.

Authors:  Ty C Voss; Gordon L Hager
Journal:  Nat Rev Genet       Date:  2013-12-17       Impact factor: 53.242

9.  HDAC1 regulates pluripotency and lineage specific transcriptional networks in embryonic and trophoblast stem cells.

Authors:  Benjamin L Kidder; Stephen Palmer
Journal:  Nucleic Acids Res       Date:  2011-12-10       Impact factor: 16.971

Review 10.  Use of epigenetic drugs in disease: an overview.

Authors:  Sarah Heerboth; Karolina Lapinska; Nicole Snyder; Meghan Leary; Sarah Rollinson; Sibaji Sarkar
Journal:  Genet Epigenet       Date:  2014-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.